Yale J F, Seemayer T A, Vigeant C
McGill Nutrition and Food Science Centre, Royal Victoria Hospital, Montreal, Canada.
Metabolism. 1988 Nov;37(11):1015-20. doi: 10.1016/0026-0495(88)90060-1.
The metabolic and cellular immune changes during adoptive transfer of type I diabetes mellitus in the BB rat were examined. Concanavalin A (Sigma Chemical Co, St Louis) stimulation of acutely diabetic BB rat splenocytes increased the Ia-positive cells, but no other lymphocyte subset. Each spleen cell preparation was divided into two and injected into two separate recipients. Thirty-day-old diabetes-prone BB rats received these splenocytes intravenously (62 +/- 5 x 10(6) cells, n = 30) or buffer alone (controls, n = 14). Seventy-seven percent of the cell-injected rats became diabetic before 60 days of age, 15 +/- 1 days after injection. They were glucose intolerant two to three days before onset, with normal fasting glucose. All controls maintained normal glucose tolerance. The morphology revealed intense insulitis in all the rats that became diabetic, and its absence in all the controls. Eighty-three percent of the spleen cell preparations produced the same outcome in both recipients. The cell-injected rats had an increase in lymphocyte counts eight days after injection compared with the controls. The most affected subsets were the pan T cells (OX19+) and helper T cells (W3/25+). While the rats that ultimately became diabetic had a decrease of their lymphocyte subsets to control levels between eight and 14 days, the injected rats that maintained normal glucose tolerance maintained elevated T cells. We conclude that (1) adoptive transfer of diabetes occurs in the presence of an increase of the helper T (W3/25+) lymphocytes after spleen cell injections; (2) glucose intolerance precedes by two to three days fasting hyperglycemia; and (3) while the lymphocyte counts are increased in all recipients of splenocyte preparations, these counts decrease rapidly only in the rats that develop diabetes, possibly by entrapment of lymphocytes in the insulitis.
研究了BB大鼠Ⅰ型糖尿病过继转移过程中的代谢和细胞免疫变化。用刀豆球蛋白A(Sigma化学公司,圣路易斯)刺激急性糖尿病BB大鼠脾细胞,可增加Ia阳性细胞,但不影响其他淋巴细胞亚群。将每份脾细胞制剂分成两份,分别注入两只不同的受体大鼠体内。30日龄的糖尿病易感BB大鼠静脉注射这些脾细胞(62±5×10⁶个细胞,n = 30)或仅注射缓冲液(对照组,n = 14)。77%的细胞注射大鼠在60日龄前、注射后15±1天患糖尿病。发病前两到三天,它们出现葡萄糖不耐受,空腹血糖正常。所有对照组均维持正常的葡萄糖耐量。形态学检查显示,所有患糖尿病的大鼠均有严重的胰岛炎,而所有对照组均无胰岛炎。83%的脾细胞制剂在两只受体大鼠中产生了相同的结果。与对照组相比,细胞注射大鼠在注射后八天淋巴细胞计数增加。受影响最大的亚群是全T细胞(OX19⁺)和辅助性T细胞(W3/25⁺)。最终患糖尿病的大鼠在八到十四天之间其淋巴细胞亚群数量降至对照水平,而维持正常葡萄糖耐量的注射大鼠T细胞数量则持续升高。我们得出以下结论:(1)脾细胞注射后,在辅助性T(W3/25⁺)淋巴细胞增加的情况下发生糖尿病过继转移;(2)空腹高血糖出现前两到三天会出现葡萄糖不耐受;(3)虽然脾细胞制剂所有受体的淋巴细胞计数均增加,但仅在患糖尿病的大鼠中这些计数迅速下降,可能是由于淋巴细胞被困在胰岛炎中。